2018 ´ëÇѹÙÀÌ·¯½ºÇÐȸ ¿¬±¸È¸¿¬ÇÕ Á¤±âÇмú´ëȸ : 2018-11-30 ±³À°ÀÏÀÚ : 2018-11-30 ±³À°Àå¼Ò : °í·Á´ëÇб³ Çϳª½ºÄù¾î ´ë°´ç ±³À°ÁÖÁ¦ : 2018 ´ëÇѹÙÀÌ·¯½ºÇÐȸ ¿¬±¸È¸¿¬ÇÕ Á¤±âÇмú´ëȸ ÁÖÃÖ±â°ü : ´ëÇѹÙÀÌ·¯½ºÇÐȸ ´ã´çÀÚ : ÃÖ¼¼ÀÎ ¿¬¶ôó : 070-8886-3062 À̸ÞÀÏ : virology@ksov.org ±³À°Á¾·ù : ¹Ì»ý¹°ÇÐ Âü¼®¿¹»óÀοø : 200¸í Èñ¸ÁÆòÁ¡ : 3Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ ¼¼ºÎ¼ö°·á : 150,000¿ø ºñ°í »çÀüµî·Ï: ȸ¿ø ÀÏ¹Ý 50,000¿ø, ȸ¿ø Çлý 30,000¿ø ºñȸ¿ø ÀÏ¹Ý 70,000¿ø, ºñȸ¿ø Çлý 40,000¿ø ÇöÀåµî·Ï: ȸ¿ø ÀÏ¹Ý 100,000¿ø, ȸ¿ø Çлý 50,000¿ø ºñȸ¿ø ÀÏ¹Ý 150,000¿ø, ºñȸ¿ø Çлý 60,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 11-30 Çϳª½ºÄù¾î ´ë°´ç 10:00~10:30 Toward a universal influenza vaccine ¹Ú¸¸¼º(°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ) ±³À°½Ã°£ 11-30 Çϳª½ºÄù¾î ´ë°´ç 10:30~11:00 Development of multivalent vaccine candidates against HFMD (hand-foot and mouth disease) ÀÌÁØ¿ì(±¹¸³º¸°Ç¿¬±¸¿ø °¨¿°º´¿¬±¸¼¾ÅÍ) ±³À°½Ã°£ 11-30 Çϳª½ºÄù¾î ´ë°´ç 11:00~11:30 Viral Entry-Associated Genome Repair of Hepatitis B Virus ·ù¿Õ½Ä(Çѱ¹ÆĽºÅ𸣿¬±¸¼Ò) ±³À°½Ã°£ 11-30 Çϳª½ºÄù¾î °ÀǽÇ2 14:10~14:40 Functional Interplay between Hepatitis C Virus and Host Small RNAs ¿ÀÁ¾¿ø(¿¬¼¼´ëÇб³) ±³À°½Ã°£ 11-30 Çϳª½ºÄù¾î °ÀǽÇ2 14:40~15:10 Recent Advances in Understanding and Cure for Hepatitis B Virus Infection ±è±Õȯ(°Ç±¹´ëÇб³) ±³À°½Ã°£ 11-30 Çϳª½ºÄù¾î °ÀǽÇ2 15:10~15:40 Sirtuin 2 isoform 1 enhances HBV replication through AKT/GSK-3beta/beta-catenin signaling pathway ±è°æ¹Î(¾ÆÁÖ´ëÇб³) ±³À°½Ã°£ 11-30 Çϳª½ºÄù¾î °ÀǽÇ2 15:40~16:10 Roles of IFN-l4 in viral hepatitis ½ÅÀÇö(Ä«À̽ºÆ®)
|